First Steps toward Harmonization of LC-MS/MS Thyroglobulin Assays

To the Editor:
Antithyroglobulin autoantibodies (TgAbs) 1 frequently cause falsely low measurements of serum thyroglobulin (Tg) when immunometric assays (TgIAs) are used (1 ) . This problem can be overcome by tryptic digestion of patient serum with subsequent measurement of Tgproteotypic peptides by LC-MS/MS (TgMS) (2) (3) (4) . However, it remains uncertain how different TgMS assays compare with each other, a crucial question in today's laboratory testing environment, wherein concern has been raised over patient samples being tested by different methods or in different laboratories over time (5 ) . We therefore performed a pilot study to assess the intermethod concordance between 4 independently developed TgMS methods. The study was approved by the Mayo Clinic institutional review board. We tested 40 patient serum samples spanning Tg concentrations from Ͻ0.1 to 10 ng/mL (assigned by DxI TgIA, Beckman Coulter). We classified the samples as TgAb positive (n ϭ 22) or TgAb negative (n ϭ 18) on the basis of whether they contained TgAb concentrations that exceeded the functional sensitivity of the DxI TgAB assays (1.8 IU/mL). Samples were deidentified and shared between 4 laboratories for Comparison of TgMS methods in the patient samples also showed good correlation (Fig. 1) Judging by the agreement in the slopes (relative SD 11.6% for TgMS vs 21.9% for TgIA) and the more favorable r 2 values (mean 0.98 for TgMS vs 0.96 for TgIA), the harmonization between the MSbased assays is at least as good as, or probably better than, the harmonization between the TgIAs. This is remarkable given the differences in target peptide, sample preparation, choice of isotopically labeled internal standards, and calibration across the 4 TgMS assays.
It is important to point out that the monoclonal antibody to the peptide FSPDDSAGASALLR was developed by the Clinical Proteomic Technologies for Cancer Initiative, a multicenter consortium funded by the National Cancer Institute from 2006 to 2011. Its direct application in the care of patients is a great advance for laboratory medicine. An expanded repertoire of antipeptide antibodies would help facilitate better patient care in other important disease areas.
The mass spectrometric measurement of Tg is resistant to the effects of autoantibodies. Our small pilot study further demonstrates that even with extensive sample preparation, multiple laboratories can achieve similar results to one another. However, additional steps toward harmonization of Tg assays will surely benefit TgMS assays as much as they would immunoassays in helping to ensure excellent comparability of results across assays in many laboratories. 
